| 120例原发性肝癌的肝动脉化疗栓塞术疗效观察 |
| |
| 引用本文： | 刘蔚,胡宗鉴,李传厅.120例原发性肝癌的肝动脉化疗栓塞术疗效观察[J].实用肝脏病杂志,2004,7(1):33-34. |
| |
| 作者姓名： | 刘蔚 胡宗鉴 李传厅 |
| |
| 作者单位： | 330008,江西省,南昌市第一医院消化内科 |
| |
| 摘 要： | 目的 观察中晚期原发性肝癌经导管肝动脉化疗栓塞术(TACE)治疗的疗效。方法自1990-2003年共有120例中晚期肝癌患者，接受TACE介入治疗，评估和随访治疗前后的疗效。结果经过治疗，79．2％(95／120)的患者临床症状缓解；88．3％(55／120)肿块缩小；78．2％(79／101)AFP明显下降；生存期延长，1、2、3年生存率分别为80．8％(87／120)、48．3％(58／120)和1130％(36／120)。结论TACE治疗是中晚期肝癌的有效手段，使不能手术切除的肝癌成为适应手术治疗，延长了患者的生命，提高了生活质量。
|
| 关 键 词： | 原发性肝癌 肝动脉化疗栓塞术 介入治疗 不良反应 手术治疗 |
| 修稿时间： | 2003年11月18 |
Transcatheter hepatic arterial chemoembolization for the treatment of 120 patients with hepatocellular carcinoma |
| |
| Liu Wei,Hu Zongjian,Li Zhuanting.Transcatheter hepatic arterial chemoembolization for the treatment of 120 patients with hepatocellular carcinoma[J].Journal of Clinical Hepatology,2004,7(1):33-34. |
| |
| Authors: | Liu Wei Hu Zongjian Li Zhuanting |
| |
| Institution: | Liu Wei,Hu Zongjian,Li Zhuanting.Department of Gastroenterology,The First Hospital,Nangchang,Jiang Xi,330008,China. |
| |
| Abstract: | Objective To observe the clinical efficiency of the treatment for the mid-advanced hapatocellular carcinoma with transcatheter hepatic arterial chemoembolization(TACE).Methods From 1990 to 2003,120 patients with HCC were treated by TACE.Results The improvement rate of symptoms and signs,decrease of alpha-fetoprotein after treatment were 79.2%,88.3%,78.2%.The surrvival time was prolonged and the 1-,2-,and 3-year survival rates were 80.3%,48.3%,and 30%,respectively.Conclusion The mid-advanced HCC with TACE can improve the response rate and survival time. |
| |
| Keywords: | Hapatoma Transcatheter hepatic arterial chemoembolization Survival |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
